137 related articles for article (PubMed ID: 15159279)
1. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.
Sprague JE; Brutcher RE; Mills EM; Caden D; Rusyniak DE
Br J Pharmacol; 2004 Jun; 142(4):667-70. PubMed ID: 15159279
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model.
Sprague JE; Moze P; Caden D; Rusyniak DE; Holmes C; Goldstein DS; Mills EM
Crit Care Med; 2005 Jun; 33(6):1311-6. PubMed ID: 15942349
[TBL] [Abstract][Full Text] [Related]
3. Role of alpha 1- and beta 3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse.
Bexis S; Docherty JR
Br J Pharmacol; 2009 Sep; 158(1):259-66. PubMed ID: 19422394
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).
Sprague JE; Banks ML; Cook VJ; Mills EM
J Pharmacol Exp Ther; 2003 Apr; 305(1):159-66. PubMed ID: 12649364
[TBL] [Abstract][Full Text] [Related]
5. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
6. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Herin DV; Liu S; Ullrich T; Rice KC; Cunningham KA
Psychopharmacology (Berl); 2005 Apr; 178(4):505-13. PubMed ID: 15765263
[TBL] [Abstract][Full Text] [Related]
7. Influence of ketanserin on the effects of methylenedioxymethamphetamine on body temperature in the mouse.
Docherty JR; Bexis S
Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):35-41. PubMed ID: 23906337
[TBL] [Abstract][Full Text] [Related]
8. Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
Chen Z; Ishizuka O; Imamura T; Aizawa N; Igawa Y; Nishizawa O; Andersson KE
Neurourol Urodyn; 2009; 28(3):251-6. PubMed ID: 18837433
[TBL] [Abstract][Full Text] [Related]
9. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
[TBL] [Abstract][Full Text] [Related]
10. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis.
Rusyniak DE; Tandy SL; Hekmatyar SK; Mills E; Smith DJ; Bansal N; MacLellan D; Harper ME; Sprague JE
J Pharmacol Exp Ther; 2005 May; 313(2):629-39. PubMed ID: 15644431
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
Vanattou-Saïfoudine N; McNamara R; Harkin A
Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
[TBL] [Abstract][Full Text] [Related]
12. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
Gramsbergen JB; Cumming P
Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
[TBL] [Abstract][Full Text] [Related]
13. Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats.
Selken J; Nichols DE
Pharmacol Biochem Behav; 2007 Apr; 86(4):622-30. PubMed ID: 17363047
[TBL] [Abstract][Full Text] [Related]
14. Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY; Dersch C; Rothman R; Cadet JL
Synapse; 1999 Sep; 33(3):207-17. PubMed ID: 10420168
[TBL] [Abstract][Full Text] [Related]
15. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
16. The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Kasai M; Shioda K; Nisijima K; Yoshino T; Iwamura T; Kato S
Neurosci Lett; 2011 Jul; 499(1):24-7. PubMed ID: 21621587
[TBL] [Abstract][Full Text] [Related]
17. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
18. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
Fantegrossi WE; Kiessel CL; Leach PT; Van Martin C; Karabenick RL; Chen X; Ohizumi Y; Ullrich T; Rice KC; Woods JH
Psychopharmacology (Berl); 2004 May; 173(3-4):270-7. PubMed ID: 14740148
[TBL] [Abstract][Full Text] [Related]
19. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
20. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.
Brown PL; Kiyatkin EA
Eur J Neurosci; 2004 Jul; 20(1):51-8. PubMed ID: 15245478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
